Literature DB >> 18508291

Host neutralizing responses and pathogenesis of hepatitis C virus infection.

Mirjam B Zeisel1, François-Loïc Cosset, Thomas F Baumert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18508291     DOI： 10.1002/hep.22307

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  19 in total

1.  EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.

Authors:  Joachim Lupberger; Mirjam B Zeisel; Fei Xiao; Christine Thumann; Isabel Fofana; Laetitia Zona; Christopher Davis; Christopher J Mee; Marine Turek; Sebastian Gorke; Cathy Royer; Benoit Fischer; Muhammad N Zahid; Dimitri Lavillette; Judith Fresquet; François-Loïc Cosset; S Michael Rothenberg; Thomas Pietschmann; Arvind H Patel; Patrick Pessaux; Michel Doffoël; Wolfgang Raffelsberger; Olivier Poch; Jane A McKeating; Laurent Brino; Thomas F Baumert
Journal:  Nat Med       Date:  2011-04-24       Impact factor: 53.440

2.  HCV entry and neutralizing antibodies: lessons from viral variants.

Authors:  Mirjam B Zeisel; Thomas F Baumert
Journal:  Future Microbiol       Date:  2009-06       Impact factor: 3.165

3.  Identification and retrospective validation of T-cell epitopes in the hepatitis C virus genotype 4 proteome: an accelerated approach toward epitope-driven vaccine development.

Authors:  Karim M Abdel-Hady; Andres H Gutierrez; Frances Terry; Joe Desrosiers; Anne S De Groot; Hassan M E Azzazy
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.

Authors:  Dorothea Bankwitz; Eike Steinmann; Julia Bitzegeio; Sandra Ciesek; Martina Friesland; Eva Herrmann; Mirjam B Zeisel; Thomas F Baumert; Zhen-yong Keck; Steven K H Foung; Eve-Isabelle Pécheur; Thomas Pietschmann
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

5.  Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies.

Authors:  Isabel Fofana; Samira Fafi-Kremer; Patric Carolla; Catherine Fauvelle; Muhammad Nauman Zahid; Marine Turek; Laura Heydmann; Karine Cury; Juliette Hayer; Christophe Combet; François-Loïc Cosset; Thomas Pietschmann; Marie-Sophie Hiet; Ralf Bartenschlager; François Habersetzer; Michel Doffoël; Zhen-Yong Keck; Steven K H Foung; Mirjam B Zeisel; Françoise Stoll-Keller; Thomas F Baumert
Journal:  Gastroenterology       Date:  2012-04-10       Impact factor: 22.682

6.  Characterization of Anti-HCV Antibodies in IL-10-Treated Patients.

Authors:  Erika A Eksioglu; Jennifer Bess; Graham Jones; Jennifer Dettloff; Parinda Dangmeon; Hui-Jia Dong; Haizhen Zhu; Roberto Firpi; Yiling Xu; David R Nelson; Chen Liu
Journal:  Viral Immunol       Date:  2010-08       Impact factor: 2.257

7.  Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation.

Authors:  Samira Fafi-Kremer; Isabel Fofana; Eric Soulier; Patric Carolla; Philip Meuleman; Geert Leroux-Roels; Arvind H Patel; François-Loïc Cosset; Patrick Pessaux; Michel Doffoël; Philippe Wolf; Françoise Stoll-Keller; Thomas F Baumert
Journal:  J Exp Med       Date:  2010-08-16       Impact factor: 14.307

8.  Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission.

Authors:  Maria Teresa Catanese; Joana Loureiro; Christopher T Jones; Marcus Dorner; Thomas von Hahn; Charles M Rice
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

Review 9.  Development of hepatitis C virus vaccines: challenges and progress.

Authors:  Françoise Stoll-Keller; Heidi Barth; Samira Fafi-Kremer; Mirjam B Zeisel; Thomas F Baumert
Journal:  Expert Rev Vaccines       Date:  2009-03       Impact factor: 5.217

Review 10.  Adaptive immune response during hepatitis C virus infection.

Authors:  Juan Ramón Larrubia; Elia Moreno-Cubero; Megha Uttam Lokhande; Silvia García-Garzón; Alicia Lázaro; Joaquín Miquel; Cristian Perna; Eduardo Sanz-de-Villalobos
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.